NDC product
Coxs Homo
NDC 43742-1794 · Deseret Biologicals, Inc.
Key facts
| Product NDC | 43742-1794 |
|---|---|
| Proprietary name | Coxs Homo |
| Nonproprietary name | Coxsackie Nosode A2, Coxsackie Nosode B1, Coxsackie Nosode B3, Coxsackie Nosode B4, Coxsackie Nosode A7 |
| Substances | HUMAN COXSACKIEVIRUS A2, HUMAN COXSACKIEVIRUS B1, HUMAN COXSACKIEVIRUS B3, HUMAN COXSACKIEVIRUS B4, HUMAN COXSACKIEVIRUS A7 |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Deseret Biologicals, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Marketing start | Sep 23, 2020 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: